High-Throughput Screening
Authors:
- Mary Jo WildeyMWMary Jo Wildey
- Anders HaunsoAHAnders Haunso
- Matthew TudorMTMatthew Tudor
- Maria WebbMWMaria Webb
- Jonathan H. ConnickJCJonathan H. Connick
- 1 January 2017
- book chapter
- Published by Elsevier
- p. 149-195
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Chemical predictive modelling to improve compound qualityNature Reviews Drug Discovery, 2013
- Impact of high-throughput screening in biomedical researchNature Reviews Drug Discovery, 2011
- Origin and evolution of high throughput screeningBritish Journal of Pharmacology, 2007
- Defining and maintaining a high quality screening collection: the GSK experienceDrug Discovery Today, 2006
- Key Aspects of the Novartis Compound Collection Enhancement Project for the Compilation of a Comprehensive Chemogenomics Drug Discovery Screening CollectionCurrent Topics in Medicinal Chemistry, 2005
- OxycodoneJournal of Pain and Symptom Management, 2005
- Initial sequencing and analysis of the human genomeNature, 2001
- Drug screening—beyond the bottleneckNature Biotechnology, 1999
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- Rational Design of Peptide-Based HIV Proteinase InhibitorsScience, 1990